Stock Market - I hear the first $25k is the hardest |
- I hear the first $25k is the hardest
- Here you go boys.
- Are we closing in on a major correction or bear market? It seems as though we are in the middle of a distribution phase. (Chart is the S&P 500)
- $100MM of DEEP ITM GME CALLS have been purchased since 3/1(Monday)
- Why the stock market is not crashing:
- I think many of us can relate...
- I remember some time ago, this was all green. Then some shit happened and all turned read. I’m starting to to be skeptical about my decisions in life! Is anyone in the same boat or is it just me ?
- Tesla and Ford flash crash in after hours. Thoughts?
- $UWMC Stock Analysis ����
- Here is a Market Recap for today Wednesday, March 3, 2021
- Noticed a trend. Past few days before closing bell. There is a significant selloff / drop in all 3 indices. Why is that?
- Coming out just in time for the opening of all AMC theaters in New York. Texas already open, will be allowed 100% capacity on 3/10
- $TRXC got FDA approved. Ticker changes Friday to $ASXC. Big presentations upcoming as well. Here's why this is a great play.
- Sector rotation before a market crash. As you may know we've seen a rotation out of energy and into staples, utilities and finance.
- Why some Chinese are buying local electric car brands like Nio — instead of Tesla
- Boomer YOLO Gains
- Bullish
- Roast/ critique my portfolio
- Evan Spiegel sold $100 Million worth of Snapchat stock today! Dont know if it was here already...
- All 8 Million of us retards need to buy at least 1 AMC share on Friday!������ All 8 Million of us retards need to buy at least 1 AMC share on Friday, it’s time to band together! Fuck the hedge funds! ������
- Cathy Wood on Benzinga - Live
- AMD Analysis: Update
- Liquidate vs Hold: New Money Scenario
- With Guardant Health ($GH) Leading the Way, the Liquid Biopsy Industry Will Be Similar To The Tech Revolution In Terms Of Size And Disruption
| I hear the first $25k is the hardest Posted: 03 Mar 2021 04:26 PM PST
 | ||
| Posted: 03 Mar 2021 05:40 PM PST
 | ||
| Posted: 03 Mar 2021 11:44 AM PST
 | ||
| $100MM of DEEP ITM GME CALLS have been purchased since 3/1(Monday) Posted: 03 Mar 2021 03:35 PM PST | ||
| Why the stock market is not crashing: Posted: 03 Mar 2021 02:08 PM PST First off, let's go straight to the point. The last few weeks have been a bloodbath for most of the market. To many, especially new traders, this seems like a full blown market crash. Well, it's not... a market crash needs a catalyst. Think back to every single crash, whether it was the dot com bubble, the housing bubble in 08, and even the flash crash on black Monday in 87' they all had a catalyst, if not many catalysts. I keep reading over and over again in the media that the bond yeilds jumping is the reason for this market crash speculation. Let's think about this for a second though - besides the fed trying to hammer home the message to investors that the bond yeilds are absolutely no cause for concern, and actually it's not even close to reaching concerning territory yet, as well as the bond yeilds are actually signaling strength in the economy - how in the world do people come to conclusion that the market is about to crash because of this? Is there any real basis to this? Ask yourself this. Another narrative that i keep seeing the media push is "the economy is overheating". Seriously? What does that even mean? The economy is recovering so fast that the market is going to crash? This has to be the most insane thing I've read yet. I can also note that the same journalists who publish this FUD about overheating, are the same journalists who will also write that the market is crashing when there is BAD economic data (such as the job report this morning). So let's ask ourselves, how can both a booming recovery and a slow, painful recovery BOTH be ingredients for a crash? I cannot comprehend how ridiculous this is becoming. Good news = market crash, bad news = market crash. What do we need for the market not to crash? I can't talk about all of this without mentioning a wild phenomenon. My portfolio. A very well diversified array of etfs which hit almost all sectors of the market. The best thing to happen to it? A global pandemic/ lockdown. The worst thing? Economic strength indicators, covid cases plummeting and vaccines and stimulus getting pumped into the masses. Has the world gone mad? Another theory that is floating around is the market being in a bubble. This is probably the most spread rumor. This one is pretty simple to shut down I think. Earnings season was insane. Comoanjes blew estimates out of the water left and right. Banks, big tech, e commerce, etc. These are the sectors that are being targeted heavily by fud in the media. These are also the companies doing the best they ever have. So how is this a bubble? Of course, companies like tesla and gamestop (lol) can be viewed and argued as in a bubble. But these companies are few and far between. My conclusion is only this. Plain and simple, fear. Fear is what's bringing this bloodbath upon us. Panic selling over irrational news articles. Just compare the VIX (fear gauge) chart with almost every single tech stock or major company's stock chart. It's literally an inverse. A mirror image. If there is anything to take away from this is that I truly believe this is just mass hysteria and it the dust will settle. Stocks will rise again. Invest in what you believe in and avoid the FUD that's being pumped out for click bait by seemingly every news outlet. Tl;dr: there is no crash. This is panic selling on a mass scale. Don't believe the media fud - the pandemic is ending and there is light at the end of this Corona virus tunnel. Buy the dip with money you can afford to potentially lose and all shall be good again on wallstreet. [link] [comments]  | ||
| I think many of us can relate... Posted: 03 Mar 2021 04:32 PM PST
 | ||
| Posted: 03 Mar 2021 07:12 PM PST
 | ||
| Tesla and Ford flash crash in after hours. Thoughts? Posted: 03 Mar 2021 03:40 PM PST
 | ||
| Posted: 03 Mar 2021 01:23 PM PST | ||
| Here is a Market Recap for today Wednesday, March 3, 2021 Posted: 03 Mar 2021 02:07 PM PST PsychoMarket Recap - Wednesday, March 3, 2021 Stocks fell for the second straight day, with technology stocks dropping sharply as the Treasury yield ticked higher once again. The S&P 500 fell 1.3%. The Nasdaq Composite fell 2.7%, the second consecutive decline for the tech-heavy index. The Dow Jones Industrial Average held up better, edging down 0.4%. President Biden said his administration expects to have enough COVID-19 vaccines for any adult that wants it by the end of May, pulling the targets two months closer than the previous government estimate. As a reminder, over the weekend, Johnson & Johnson's (JNJ) single dose vaccine received emergency use authorization from the Food and Drug Administration (FDA), making it the third coronavirus vaccine available in the US, following Pfizer (PFE) and Moderna (MRNA). Drugmaker Merck (MRK) announced it was going to help Johnson & Johnson produce its coronavirus vaccine. In other news, lawmakers in the Senate are set to begin debating President Biden's $1.9 trillion stimulus, which was passed by the House of Representatives recently. Democrats are racing to push the legislation forward before the mid-March expiry of augmented Federal unemployment benefits. Republicans do not support the bill because of its size, but through a process called reconciliation. Reconciliation is a way for Congress to enact legislation on taxes, spending, and the debt limit with a simple majority (51 votes, or 50 if the vice president breaks a tie) in the Senate, avoiding the threat of a filibuster, which requires a 60 vote supermajority to overcome. Because Democrats have 50 seats in the Senate—plus a Democratic vice president—reconciliation is a way to get a tax-and-spending bill to the president's desk even if all 50 Republicans oppose it The likelihood of more stimulus and widespread business reopenings as the vaccine is distributewd has raised the specter of both speedy growth in the U.S. economy and rising inflationary pressures. Last week's jump in Treasury yields – with the benchmark 10-year yield reaching a one-year high of 1.61% – remains fresh in the minds of investors, who have been eyeing the rise in interest rates as a possible hindrance to the recovery and deviation from last year's ultra-low borrowing costs backdrop. The 10-year Treasury yield currently sits at 1.48% at the time of writing. Highlights
[link] [comments]  | ||
| Posted: 03 Mar 2021 01:06 PM PST
 | ||
| Posted: 03 Mar 2021 10:35 AM PST
 | ||
| Posted: 03 Mar 2021 05:56 AM PST I'll start by saying TRXC got FDA approved on their amazing Senhance Surgery equipment early this morning, the catalyst many folks have been waiting for just happened. TRXC is still in the early stages of commercializing its Senhance surgical robotic system. The platform introduces several pioneering functions and capabilities representing a differentiation compared to alternatives on the market. The company notes that Senhance is the first robotic system with AI and machine vision capabilities incorporating proprietary software technology. Senhance also is the first to use a haptic feedback control for the practicing surgeon which it believes offers superior precision relative to hand movements other platforms use. As it relates to laparoscopy, surgeons will likely feel comfortable as the system uses the familiar seated position enhanced with a 3D visualization including eye-tracking technology and remote type controls. Any discussion of robotic surgery needs to include Intuitive Surgical Inc with its market-leading "Da Vinci" robotic-assisted surgery system. Several aspects make Senhance different and potentially a superior product. Again, the seat console positioning of Senhance is ideal for laparoscopic surgery while the Da Vinci may be more appropriate for other applications. In this regard, Senhance isn't necessarily attempting to replace Da Vinci for all types of operations, but instead offer a more specialized solution with an alternative technique. Notably, Senhance instruments are fully reusable while Da Vinci typically requires limited usage with a max of 10-15 procedures which add to costs. The Senhance system also is using 5mm and 3mm articulating instruments which are more precise than the 8mm standard on Da Vinci. The company explains that the smaller size represents an advantage with improved invasiveness. Senhance's open vision camera system and integration of computer assistance is an additional value driver. TRXC highlights the large and fast-growing market for surgical robotics with laparoscopic robotic surgery representing a significant greenfield opportunity. The company estimates that the $3.7 billion abdominal robotic surgery market in 2018 may grow by over 4x through 2023 to $16 billion. Between the 10 million abdominal surgical procedures performed in the U.S. and Europe each year, 4 million are "open surgeries" which are based on a traditional large scalpel incision. From this group, current robotic surgery penetration is estimated to be around 25%, largely captured by Da Vinci. In turn, the 6 million Laparoscopic surgeries performed each year, which are minimally invasive procedures, only have limited robotic penetration. This is the core initial addressable market for TRXC. While robotic surgery has gained adoption over the past decade, TRXC is a significant opportunity in the Laparoscopic field where there are limited current robotic applications. The product already has been cleared by the FDA and approved across Europe and Japan with the company focusing on building clinical adoption. Shares are up over 550% in the last six months with an expectation that further regulatory approvals for expanded indications can support higher growth. According to many analysts the outlook is positive with the company gaining momentum in 2021. [link] [comments]  | ||
| Posted: 03 Mar 2021 07:13 AM PST
 | ||
| Why some Chinese are buying local electric car brands like Nio — instead of Tesla Posted: 02 Mar 2021 09:25 PM PST
 | ||
| Posted: 03 Mar 2021 07:48 PM PST
 | ||
| Posted: 03 Mar 2021 12:31 PM PST
 | ||
| Posted: 03 Mar 2021 06:53 PM PST Hey everyone long time lurker finally becoming active and posting. I have been investing for under a year now. I am 28 years old with 2 kids... my financial goals is to long term invest for the next 15+ years in order to pay for their education and to buy them each a car when they turn 16. I am currently 76% stocks and 24% ETFs I would like to increase my ETF holdings and decrease the Stock %. My goal is to stay diversified and not overlap as much as i can but also invest in solid companies (i try to avoid the yolo meme stocks). So here is my portfolio with %'s and then my future plans for it. Please give me your best opinions/ advice (cross posted for best results of advice)! ETFs (24%) QQQj (2.81%), ARKG (0.78%), PRNT (1.66%), ARKK (3.25%), ARKQ (4.26%), ARKF (2.36%), SMG (4.05%), SUBZ (1.25%), ARKW (1.36%), BETZ (1.93 %) Stocks (76%) Disney (8.38%), Airbnb (6.27%), OPEN (2.45%), Z (6.45%), ROKU (12.82%), Apple (5.3%), NVTA (1%), PYPL (11.03%, SQ (12.18%), TDOC (5.27%), PACB (0.81%), CRSP (2.06%), PLTR (2.16%) My goals when i do my next buying round this month... Increase positions on BETZ, ARKK, ARKW, SMH, ARKG, ARKF, ARKQ, ARKQ, PRNT in order to get all ETFs close to an evenly split percent. which will effectively increase overall portfolios etf percent also. I also plan to add to my positions of ABNB, CRSP, PACB, NVTA in order to even out my holdings there. Right now i am way too heavy on ROKU (stocks down so just holding it) I am heavy on SQ/ PYPL also but thats on purpose because i believe those are very solid long term. TDOC is actually heavier than i anticipated but will be holding long term. PLTR is my only yolo/ memeish stock i hold. Over time (next 3-6 months) i plan to add in QQQ to my ETF mix. So my question is this... how does it look? I feel like i have touched a few different sectors with fintech, travel, betting/ gambling, streaming/ entertainment, communcation/ semiconductors, geonomics, healthcare, autonomous, innovation, and defense. I was looking at CIBR/ HACK but felt unsure and i was also looking at adding FIVG/ NXTG but i also felt unsure on these. Would you add any ETFs, do you think any overlap too much? My kinda goal is to own an ETF and then effectively also own 1-3 stocks in said sector. Like i said my main goal is to add to my ETF holdings first to even out that distribution which right now really isnt too heavy one way or the other which is good and then fill a few more stocks to even that out. I do plan to decrease the ROKU position once that recovers fully which will help with my weight. Stock wise i believe the only ones over time i feel good about adding to on dips would be Apple right now (would like to see it more evenly with SQ/ PYPl) and Disney). thanks for any input!! [link] [comments]  | ||
| Evan Spiegel sold $100 Million worth of Snapchat stock today! Dont know if it was here already... Posted: 03 Mar 2021 05:05 PM PST
 | ||
| Posted: 03 Mar 2021 07:48 PM PST
 | ||
| Posted: 03 Mar 2021 11:10 AM PST
 | ||
| Posted: 03 Mar 2021 02:47 PM PST
 | ||
| Liquidate vs Hold: New Money Scenario Posted: 03 Mar 2021 02:34 PM PST Dumped 80k in 3 weeks ago. 70% SCHB, 25% VXUS, 2.5% SPACs 2.5% PLTR. Don't plan on needing this money until retirement (unless some stupid crazy emergency my emergency and house funds couldn't cover). I'm down about $1k if I sold right now. Should I sell and buy back in at a later date given current market conditions or just delete the app and ignore it for the next 6 months? Guess I'm nervous that this is only the beginning and recovery will be years instead of months. I'd hate for this money to be lost for years and years before finally appreciating. That would be a massive loss in opportunity cost. Guess the flipside would be we recover over the next month and then back up by April/May and I lose out by being to afraid to buy back in by then or losing put if I decide to DCA. I understand time > timing and lump-sum trumps DCA most of the time, but my concern is this being the other time. Last time I lump-summed was a month before 2018 correction and the week prior to the 2020 crash, so that's where my fears are coming from as well. Granted, those were closer to 10k a pop, not 80k haha. Easier to stomach and less FUD, I feel. Appreciate any insight. Thanks. [link] [comments]  | ||
| Posted: 03 Mar 2021 06:05 PM PST Having done a bit of DD on Guardant Health ($GH) I wanted to share my views on the company. As always, I appreciate any and all feedback. While other companies are making significant strides in early cancer detection (i.e. Exact Sciences ($EXAS) and Illumina ($ILMN), as well as Google-backed Freenome), I believe Guardant is a true disruptor in the life sciences industry. Guardant is a precision oncology company with a specific focus in liquid biopsy. Unlike a traditional tissue biopsy, their liquid biopsies use a simple blood test that produces quicker results and is significantly less invasive. For example, consider screening for Colon cancer via blood draw instead of having to undergo a two-day colonoscopy. Guardant is then able to perform an analysis of the blood to detect fragments of DNA from tumor cells in the blood. Guardant distinguishes itself from other liquid biopsy companies in a few important ways. Their CDx solution is the first FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling across all solid cancers. This is a companion to GH's flagship product, Guardant360, which is already a huge commercial success - and gives GH a competitive advantage over their competitors, i.e. 2cureX, which is working on similar solutions. Additionally, GH has recently begun its ECLIPSE trial for the early detection of colorectal cancer in asymptomatic patients. With trial enrollment ending in Oct/Nov we will likely see some data around mid-year. Most importantly, this trial essentially serves as the backbone of GH's broader early cancer detection program, and provides a roadmap for success that I believe the other competing liquid biopsy companies currently do not have. Finally, Guardant has a market cap of <$15bn, which compared to Illumina and Exact Science (~$61bn and ~$21.5bn, respectively) is positioned well for substantial growth. And although Q1 earnings fell a bit short on conservative guidance, Guardant still posted nearly $287 million in full-year 2020 revenue (34% revenue growth YoY). Historically, the stock has performed extremely well, and the overwhelming majority of analysts have maintained strong buys and raised price targets (i.e., Citigroup, from $155 to $190, Cowen & Co., from $140 to $190. and Morgan Stanley, from $130 to $175). I would love to hear if others agree/disagree. Needless to say, I am very optimistic about Guardant's achievements in early cancer detection through the development of its innovative blood tests, and see this not only as a great investment opportunity, but them as a disruptive force within the industry. Of course, if there are other investment opportunities that folks are similarly excited about, I am always interested to hear as well! [link] [comments]  |
![[link]](https://i.redd.it/a4gb8w8xnvk61.jpg){kind=link}
![[link]](https://i.redd.it/qol5o3ly9vk61.png){kind=link}
![[link]](https://i.redd.it/8p9jmawbpwk61.jpg){kind=link}
![[link]](https://i.redd.it/6zuxm5vshxk61.jpg){kind=link}
![[link]](https://i.redd.it/724mvup3gwk61.png){kind=link}
![[link]](https://i.redd.it/sf7a8lwmovk61.jpg){kind=link}
![[link]](https://i.redd.it/k6ayv1zkxuk61.jpg){kind=link}
![[link]](https://i.redd.it/jqbbkgvixtk61.jpg){kind=link}
![[link]](https://i.redd.it/gbrmcjh9oxk61.jpg){kind=link}
![[link]](https://i.redd.it/7p9upuiaivk61.jpg){kind=link}
![[link]](https://i.redd.it/nxbsp2i3vwk61.png){kind=link}
![[link]](https://i.redd.it/0dqzh4wcoxk61.jpg){kind=link}
| You are subscribed to email updates from r/StockMarket - Reddit's Front Page of the Stock Market. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment